Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry

Back

EHRA Premium Access

Quality of life and 12-month efficacy outcomes in paroxysmal and persistent af following pvi using the pvac gold ablation catheter: results from the multicenter GOLD AF registry

Session: Late-breaking trials 1

Topic: Rhythm Control, Catheter Ablation

Speaker: Professor L. Boersma (Nieuwegein, NL)

Event: EHRA 2019

Congress Presentation

Add to my library

About the speaker

Professor Lucas Boersma

St Antonius Hospital, Nieuwegein (Netherlands (The))

39 presentations

4 followers

10 more presentations in this session

A randomized clinical trial of cryoballoon vs. irrigated radiofrequency catheter ablation for atrial fibrillation:The CIRCA-DOSE Study

Speaker: Doctor J. Andrade (Vancouver, CA)

Access

Slides

Video

CIRCA-DOSE Study - Discussion

Speaker: Professor D. Scherr (Graz, AT)

Access

Slides

Video

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - AVATAR AF

Speaker: Professor P. Kanagaratnam (London, GB)

Access

Slides

Video

Ablation versus anti-arrhythmic therapy for reducing all hospital episodes from recurrent atrial fibrillation - Discussion

Speaker: Professor J. Merino (Madrid, ES)

Access

Slides

Video

GOLD AF registry - Discussion

Access

Slides

Video

Access the full session

Late-breaking trials 1

Speakers: Professor L. Boersma, Doctor J. Andrade, Professor D. Scherr, Professor P. Kanagaratnam, Professor J. Merino

Access

About the event

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources